{"id":"W2055375232","doi":"10.1007/s11239-013-0885-0","title":"Reversal of novel oral anticoagulants in patients with major bleeding","year":2013,"lang":"en","type":"review","venue":"Journal of Thrombosis and Thrombolysis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Dabigatran; Edoxaban; Apixaban; Prothrombin complex concentrate; Major bleeding; Intensive care medicine; Warfarin; Discovery and development of direct thrombin inhibitors; Anticoagulant; Recombinant factor VIIa; Clinical trial; Thrombin; Anesthesia; Internal medicine; Atrial fibrillation; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007340644,0.000604993,0.002955011,0.001376423,0.0001330643,0.0007807907,0.001002385,0.0010119,0.002067223],"category_scores_gemma":[0.001877724,0.0002886351,0.001183852,0.0009305669,0.0002921328,0.0008186756,0.0003251143,0.001608416,0.0003530678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003111944,"about_ca_system_score_gemma":0.0007539418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008048632,"about_ca_topic_score_gemma":0.002023853,"domain_scores_codex":[0.9996095,0.00007426326,0.0001204416,0.00005850789,0.0001144537,0.00002284116],"domain_scores_gemma":[0.9992623,0.0004189915,0.000212808,0.00001082437,0.00007004139,0.00002515301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001130971,0.0002149381,0.0009690194,0.05668881,0.001420804,0.0003747082,0.0000603832,0.0002222833,0.001266954,0.0005275772,0.01007848,0.9270452],"study_design_scores_gemma":[0.0072597,0.006034503,0.02889686,0.08666009,0.02615037,0.01399573,0.0004675346,0.00163107,0.004042575,0.002990196,0.8215947,0.0002767695],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004410019,0.9990665,0.0000677566,0.0001068434,0.00006974334,0.000006312932,0.00001181339,0.000004107496,0.0002258536],"genre_scores_gemma":[0.004624512,0.9944378,0.0002626018,0.0002830491,0.0001895833,0.00001252581,0.00003937417,0.000001365788,0.0001491843],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002955011,"threshold_uncertainty_score":0.006915629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1398789138690641,"score_gpt":0.3803874706346193,"score_spread":0.2405085567655552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}